Effect of cupping on respiratory symptoms of COVID-19

INTERVENTION: Intervention 1: Intervention group: Patients in this group receive the treatment of COVID‐19 according to the protocol of the Ministry of Health, in addition, they should receive cupping therapy using special disposable plastic cups for cupping therapy, for each patient, for 5 days, once a day for 15 to 20 minutes in the back of the chest (3 glasses on each side). Intervention 2: Control group: Patients in this group receive medication for COVID‐19 according to the Ministry of Health protocol. CONDITION: COVID‐19. ; COVID‐19, virus identified U07.1 PRIMARY OUTCOME: Dyspnea. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of cupping. Method of measurement: By using a pulse oximeter and asking the patient. SECONDARY OUTCOME: Cell blood count. Timepoint: At the beginning of the study (before the start of the intervention) and on the 5th day after the start of the cupping. Method of measurement: Cell Counter device. Chest CT scan. Timepoint: At the beginning of the study (before the start of the intervention) and on the 5th day, if requested by the treating physician, it will be recorded. Method of measurement: CT scan set. Chest X‐ray. Timepoint: At the beginning of the study (before the start of the intervention) and on the 5th day after the start of the cupping. Method of measurement: Radiology set. CRP. Timepoint: At the beginning of the study (before the start of the intervention) and on the 5th day after the start of the cupping. Method of measurement: Agglutination kit. Dry cough. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the cupping. Method of measurement: By asking the patient. ESR. Timepoint: At the beginning of the study (before the start of the intervention) and on the 5th day after the start of the cupping. Method of measurement: Sed rate device. Fever. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the medical beer. Method of measurement: Mercury thermometer (oral). Muscular pain. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the cupping. Method of measurement: By asking the patient and the Visual Analog Scale (VAS) score. INCLUSION CRITERIA: Patients aged 18 to 60 years Diagnosis confirmation by the cooperative infectious disease specialist in the project Patient's consent to participate in the project With inpatient clinical criteria (fever above 38° C or severe cough or shortness of breath or respiratory rate more than 24 per minute or oxygen saturation lower than 93%) Positive PCR